IP Library Granted Patent US 7,098,221
Granted Patent B2
US 7,098,221 · App. 11/200,556 · Granted Aug 29, 2006

Amide substituted imidazopyridines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,098,221
App. No.
11/200,556
Granted
Aug 29, 2006
Kind
B2
Abstract

Imidazopyridine compounds that contain amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Claims (30)

1. A method of inducing cytokine biosynthesis in an animal comprising administering a therapeutically effective amount of a compound of the formula (I):

wherein

X is C 1-10 alkylene;

Y is —CO—;

Z is a bond;

R 1 is C 1-10 alkyl;

R 2 is selected from the group consisting of:

C 1-4 alkyl,

ethoxymethyl, and

methoxyethyl;

R 3 and R 4 are methyl; and

R 5 is hydrogen;

or a pharmaceutically acceptable salt thereof to the animal;

wherein the cytokine is IFN-α or TNF-α.

2. The method of claim 1 wherein X is propylene, butylene, or —CH 2 —C(CH 3 ) 2 —.

3. A method of inducing cytokine biosynthesis in an animal comprising administering a therapeutically effective amount of a compound of the formula (I):

wherein

X is C 1-10 alkylene;

Y is —CO—;

Z is a bond;

R 1 is C 1-6 alkyl;

R 2 is selected from the group consisting of:

C 1-4 alkyl,

ethoxymethyl, and

methoxyethyl;

R 3 and R 4 are methyl; and

R 5 is hydrogen, or R 1 and R 5 join to form a ring;

or a pharmaceutically acceptable salt thereof to the animal;

wherein the cytokine is IFN-α or TNF-α.

4. The method of claim 3 wherein R 1 is C 1-4 alkyl.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2007
From: 3M COMPANY; 3M INNOVATIVE PROPERTIES COMPANY
To: COLEY PHARMACEUTICAL GROUP, INC.
Reel/Frame 019965/0551 →